Alice Lione – Pagina 31 – AMD

Alice Lione

Marzo 26, 2026 Alice Lione

Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial

Rosenstock J, Yabe D, Cox D, et al.
Lancet. Pub. online 21 Mar 2026.

Leggi

Marzo 26, 2026 Alice Lione

Advancing type 2 diabetes care: the role of continuous glucose monitoring in noninsulin-treated patients

Gavin JR, Virdi N
Diabetes Obes Cardiometab Care. Pub. online 16 Mar 2026.

Leggi

Marzo 26, 2026 Alice Lione

Polygenic background contributes to GCK-MODY clinical presentation and glycaemic variability

Murray Leech J, Arni AM, Chundru VK, et al.
Diabetologia. Pub. online 18 Mar 2026.

Leggi

Marzo 26, 2026 Alice Lione

Artificial intelligence in type 1 diabetes management: a scoping review of randomised controlled trials

Wu Y, Pang J, Xu S, et al.
Diabetes Obes Metab. Pub. online 19 Mar 2026.

Leggi

Marzo 26, 2026 Alice Lione

Dementia risk in type 1 and 2 diabetes: a nationwide population‐based comparison

Jun JE, Kim S, Jeong IK, et al.
Diabetes Obes Metab. Pub. online 19 Mar 2026.

Leggi

Marzo 26, 2026 Alice Lione

Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer’s disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials

Cummings JL, Atri A, Sano M, et al.
Lancet. Pub. online 19 Mar 2026.

Leggi

Marzo 24, 2026 Alice Lione

American Association of Clinical Endocrinology consensus statement: algorithm for management of adults with type 2 diabetes – 2026 update

Samson SL, Vellanki P, Blonde L, et al.
Endocr Pract. Pub. online 17 Mar 2026.

Leggi

Marzo 23, 2026 Alice Lione

Data-driven phenotypic clusters of gestational diabetes mellitus and associations with risk of perinatal complications and postpartum diabetes

Zhu Y, Ngo AL, Liao LD, et al.
Diabetes Care. Pub. online 17 Mar 2026.

Leggi

Marzo 23, 2026 Alice Lione

A type 2 diabetes policy model that predicts remaining life expectancy, quality-adjusted life expectancy and healthcare costs for use in economic evaluation, incorporating equity concerns

Wei L, Haghpanahan H, Wild SH, et al.
Diabetes Obes Metab. Pub. online 19 Mar 2026.

Leggi

Marzo 23, 2026 Alice Lione

Highly uncontrolled cardiovascular risk in emerging adults with paediatric-onset type 1 diabetes-a cross-sectional analysis from the diabetes prospective follow-up registry DPV

Welters A, Reinauer C, Schwab KO, et al.
Diabetes Obes Metab. Pub. online 16 Mar 2026.

Leggi